EXPD
48
5
ECL
59
-3
ILMN
42
-3
NUE
53
-5
CVX
47
9
PSA
55
-3
HRL
39
9
DE
39
3
TAP
60
-4
HST
43
-7
SPG
60
-3
ORCL
68
-3
FDX
44
-10
FLR
50
2
PCAR
62
-2
NKE
31
-2
WDC
41
3
PM
64
6
GS
69
-6
NI
70
-3
EXPD
48
5
ECL
59
-3
ILMN
42
-3
NUE
53
-5
CVX
47
9
PSA
55
-3
HRL
39
9
DE
39
3
TAP
60
-4
HST
43
-7
SPG
60
-3
ORCL
68
-3
FDX
44
-10
FLR
50
2
PCAR
62
-2
NKE
31
-2
WDC
41
3
PM
64
6
GS
69
-6
NI
70
-3
Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
73

VERA
Vera Therapeutics

Last Price:
48.99
Seasonality Move:
65.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Vera Therapeutics Price Quote

$48.99
-0.01 (-0.83%)
(Updated: November 15, 2024 at 4:52 AM ET)

Vera Therapeutics Key Stats

Buy
73
Vera Therapeutics (VERA) is a Buy
Day range:
$48.06 - $50.19
52-week range:
$12.28 - $51.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
10.73%
Volume:
642.4K
Avg. volume:
918.2K
1-year change:
259.77%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-2.61

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $353.3M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 5.25

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.6M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $305.5M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$185.1M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • PROCEPT BioRobotics Corp (PRCT)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Vera Therapeutics Dividend Yield

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.73%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 63.91
Upside from Last Price: 30.43%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    76.6M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    615.9K VERA shares are owned by insiders